Fostamatinib clinical trials

Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection

This study looks at a new drug, Fostamatinib, for kidney transplant patients whose bodies are rejecting their new kidney. It aims to see if the drug is safe and helps stop the rejection from getting worse.